Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||||
net income | 96,541,000 | 58,734,000 | 61,975,000 | 79,205,000 | 71,273,000 | 69,742,000 | 74,175,000 | 69,270,000 | 65,202,000 | 54,895,000 | 55,741,000 | 44,720,000 | 57,166,000 | 37,589,000 | 25,992,000 | 14,383,000 | 14,527,000 | 20,590,000 | 18,675,000 | 10,524,000 | |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||
benefit from deferred income taxes | 12,737,000 | 12,168,000 | 7,275,000 | 13,139,000 | 7,894,000 | 3,372,000 | 5,493,000 | 4,354,000 | 6,269,000 | 9,160,000 | 13,532,000 | 4,725,000 | 7,182,000 | -4,055,000 | 235,000 | 1,715,000 | 1,360,000 | -835,000 | 2,746,000 | -1,156,000 | 3,361,000 |
depreciation and amortization | 22,032,000 | 21,794,000 | 7,432,000 | 10,758,000 | 10,607,000 | 5,384,000 | 4,377,000 | 4,694,000 | 4,385,000 | 4,229,000 | 3,936,000 | 4,166,000 | 4,050,000 | 5,620,000 | 7,768,000 | 5,263,000 | 5,222,000 | 5,360,000 | 5,574,000 | 5,931,000 | 6,412,000 |
deferred financing costs, accretion expense and derivative gains/losses | -3,461,000 | -3,104,000 | -3,068,000 | ||||||||||||||||||
stock-based and deferred compensation | 15,972,000 | 13,978,000 | 3,660,000 | 2,203,000 | 4,792,000 | 4,303,000 | 7,005,000 | 9,471,000 | 4,741,000 | 6,674,000 | 2,772,000 | 5,185,000 | 4,819,000 | 3,924,000 | 5,084,000 | 5,181,000 | 4,253,000 | ||||
change in fair value of contingent consideration obligations | 3,841,000 | 1,092,000 | 3,406,000 | -26,600,000 | -3,500,000 | 3,200,000 | 2,400,000 | 5,700,000 | 2,500,000 | 9,500,000 | 2,000,000 | 5,300,000 | -5,500,000 | 19,900,000 | 0 | ||||||
unrealized depreciation (appreciation) on investments | -2,657,000 | -4,338,000 | 835,000 | 452,000 | -2,720,000 | -837,000 | -2,702,000 | 4,971,000 | -1,458,000 | 3,133,000 | -139,000 | -246,000 | 124,000 | ||||||||
noncash lease expense | 162,000 | 120,000 | 82,000 | 102,000 | 94,000 | ||||||||||||||||
loss on debt extinguishment | 963,000 | 1,555,000 | 0 | 669,000 | 1,146,000 | 2,781,000 | 1,196,000 | 758,000 | -137,000 | 1,054,000 | 2,451,000 | 0 | 0 | 0 | 6,058,000 | ||||||
changes in operating assets and liabilities: | |||||||||||||||||||||
receivables | 26,016,000 | -63,259,000 | 4,289,000 | 9,209,000 | 4,210,000 | -4,489,000 | -3,570,000 | -6,730,000 | -3,757,000 | 2,805,000 | 16,439,000 | -11,300,000 | 261,000 | -327,000 | 2,267,000 | 1,999,000 | 1,104,000 | ||||
prepaid expenses | -507,000 | 2,338,000 | -271,000 | 153,000 | -1,260,000 | -818,000 | 661,000 | 547,000 | -695,000 | -747,000 | 917,000 | 457,000 | -1,857,000 | -186,000 | -868,000 | 94,000 | -1,181,000 | -171,000 | 361,000 | ||
other assets | 520,000 | 665,000 | 666,000 | -6,000 | -80,000 | 0 | 0 | -25,000 | 32,000 | -18,000 | -793,000 | -47,000 | -101,000 | 3,000 | -270,000 | 425,000 | |||||
accounts payable and accrued expenses | -8,225,000 | -15,197,000 | 13,836,000 | -7,858,000 | -8,819,000 | 8,827,000 | 4,908,000 | -7,866,000 | 13,573,000 | -21,545,000 | -855,000 | -11,760,000 | 66,179,000 | 2,849,000 | 5,685,000 | -467,000 | -4,386,000 | 2,166,000 | |||
accrued compensation and benefits | 5,886,000 | -9,542,000 | -18,155,000 | 5,004,000 | -13,487,000 | 10,292,000 | 5,742,000 | 4,101,000 | -14,987,000 | 6,374,000 | 6,887,000 | 3,109,000 | -23,990,000 | 10,199,000 | 17,172,000 | 1,660,000 | -10,331,000 | 74,000 | 6,386,000 | ||
other liabilities | -3,564,000 | -22,041,000 | -868,000 | -801,000 | -146,000 | 508,000 | -499,000 | 536,000 | -490,000 | -358,000 | -1,644,000 | -437,000 | 239,000 | 1,344,000 | 1,646,000 | -39,000 | -80,000 | 256,000 | -3,086,000 | 3,138,000 | 138,000 |
net cash from operating activities | 165,907,000 | -6,592,000 | 81,094,000 | 90,242,000 | 74,813,000 | 112,135,000 | 99,889,000 | 84,538,000 | 79,634,000 | 67,896,000 | 61,809,000 | 68,989,000 | 51,922,000 | 59,699,000 | 118,407,000 | 31,340,000 | 17,938,000 | 34,448,000 | 40,305,000 | 33,720,000 | 25,872,000 |
capex | -1,079,000 | -890,000 | -1,589,000 | -1,734,000 | -1,176,000 | -4,376,000 | -2,731,000 | -5,174,000 | -393,000 | -1,013,000 | -1,766,000 | -4,572,000 | -708,000 | -2,319,000 | -2,028,000 | -408,000 | -484,000 | -804,000 | -434,000 | 0 | 0 |
free cash flows | 164,828,000 | -7,482,000 | 79,505,000 | 88,508,000 | 73,637,000 | 107,759,000 | 97,158,000 | 79,364,000 | 79,241,000 | 66,883,000 | 60,043,000 | 64,417,000 | 51,214,000 | 57,380,000 | 116,379,000 | 30,932,000 | 17,454,000 | 33,644,000 | 39,871,000 | 33,720,000 | 25,872,000 |
cash flows from investing activities | |||||||||||||||||||||
purchases of property and equipment | -1,079,000 | -890,000 | -1,589,000 | -1,734,000 | -1,176,000 | -4,376,000 | -2,731,000 | -5,174,000 | -393,000 | -1,013,000 | -1,766,000 | -4,572,000 | -708,000 | -2,319,000 | -2,028,000 | -408,000 | -484,000 | -804,000 | -434,000 | ||
purchases of investments | -8,822,000 | -28,874,000 | -1,526,000 | -7,678,000 | -2,365,000 | -3,852,000 | -2,937,000 | -2,626,000 | -945,000 | ||||||||||||
sales of investments | 9,403,000 | 55,992,000 | 1,431,000 | 6,932,000 | 1,249,000 | 3,247,000 | 2,111,000 | 1,909,000 | 16,000 | 180,000 | 448,000 | ||||||||||
cash acquired from acquisition | 40,000 | ||||||||||||||||||||
net cash from investing activities | -458,000 | 79,800,000 | -1,684,000 | -3,033,000 | -4,119,000 | -545,556,000 | -3,715,000 | -6,177,000 | -1,140,000 | -1,820,000 | -3,589,000 | -4,697,000 | -2,234,000 | -3,924,000 | -843,377,000 | -1,064,000 | -1,447,000 | -3,894,000 | -2,363,000 | ||
cash flows from financing activities | |||||||||||||||||||||
issuance of common stock | 342,000 | 831,000 | 549,000 | 1,771,000 | 1,302,000 | ||||||||||||||||
repurchase of common stock | -118,510,000 | -25,964,000 | -451,000 | -19,170,000 | -10,193,000 | -5,661,000 | -8,183,000 | -10,028,000 | -7,661,000 | -7,054,000 | -9,764,000 | -7,037,000 | -6,020,000 | -6,193,000 | -5,816,000 | -1,883,000 | -1,643,000 | -4,497,000 | -2,961,000 | ||
payments of taxes related to net share settlement of equity awards | -2,171,000 | -8,696,000 | -885,000 | -3,183,000 | -5,373,000 | -4,585,000 | -11,026,000 | -3,469,000 | -7,614,000 | -2,964,000 | -1,265,000 | -3,449,000 | -4,431,000 | -4,162,000 | -3,261,000 | -40,000 | -196,000 | 0 | |||
payment of debt financing fees | 0 | -1,000 | -78,000 | ||||||||||||||||||
payments of long-term senior debt | |||||||||||||||||||||
proceeds from long-term senior debt | 0 | 0 | 0 | 0 | 359,100,000 | ||||||||||||||||
payment of dividends | -42,073,000 | -43,704,000 | -29,926,000 | -17,358,000 | -17,381,000 | -11,750,000 | -10,771,000 | -8,245,000 | -6,393,000 | -4,718,000 | -4,510,000 | -3,518,000 | -3,490,000 | -3,452,000 | -3,919,000 | -24,000 | -41,000 | -137,000 | -497,000 | ||
payment of consideration for acquisition | 0 | 0 | 1,000 | ||||||||||||||||||
net cash from financing activities | -157,474,000 | -141,266,000 | -30,713,000 | -82,940,000 | -101,645,000 | 438,202,000 | -63,015,000 | -77,136,000 | -70,834,000 | -99,689,000 | -57,176,000 | -46,258,000 | -49,573,000 | -97,692,000 | 708,646,000 | -1,196,000 | -1,742,000 | -4,193,000 | -27,955,000 | ||
effect of changes of foreign exchange rate on cash and cash equivalents | -104,000 | 321,000 | 179,000 | -101,000 | -32,000 | 12,000 | -41,000 | 11,000 | -18,000 | 73,000 | 56,000 | 20,000 | -106,000 | 75,000 | -40,000 | -14,000 | 21,000 | -9,000 | -10,000 | -85,000 | 39,000 |
net decrease in cash and cash equivalents | 7,871,000 | ||||||||||||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 126,731,000 | 0 | 69,533,000 | 0 | 0 | 0 | 22,744,000 | 0 | 0 | 0 | 37,121,000 | 0 | 51,491,000 | 0 | 0 | 0 | 12,921,000 | ||
cash and cash equivalents, end of period | 7,871,000 | -67,737,000 | 175,607,000 | 4,168,000 | 38,550,000 | 4,793,000 | 33,118,000 | 1,236,000 | 30,386,000 | -33,540,000 | 1,100,000 | 18,054,000 | 37,130,000 | -41,842,000 | 66,261,000 | 26,352,000 | 9,977,000 | 2,866,000 | 12,296,000 | ||
supplemental cash flow information | |||||||||||||||||||||
cash paid for interest | 30,025,000 | 16,134,000 | 17,227,000 | 7,406,000 | 7,074,000 | 3,962,000 | 4,239,000 | 2,471,000 | 8,096,000 | 6,316,000 | 9,075,000 | 3,184,000 | 20,112,000 | 15,238,000 | 717,000 | 3,698,000 | 3,801,000 | 3,755,000 | 3,639,000 | 3,973,000 | 6,163,000 |
cash paid for income taxes | 11,928,000 | 41,835,000 | 1,503,000 | 22,142,000 | 1,012,000 | 6,016,000 | 14,956,000 | 33,350,000 | 831,000 | 10,083,000 | 24,460,000 | 1,924,000 | 1,345,000 | 15,094,000 | 2,664,000 | 6,533,000 | 343,000 | 6,284,000 | 6,872,000 | ||
noncash items | |||||||||||||||||||||
operating lease right-of-use assets obtained in exchange for new operating lease liabilities | -34,272,000 | 0 | 2,991,000 | ||||||||||||||||||
non-cash investing and financing activities: | |||||||||||||||||||||
issuance of 3.3 million shares of common stock and 19.7 million shares of preferred stock in connection with the acquisition of amundi us | -2,358,000 | ||||||||||||||||||||
repayment of long-term senior debt | -70,000,000 | -50,000,000 | -32,287,000 | -38,000,000 | -85,000,000 | 0 | -20,000,000 | ||||||||||||||
net increase in cash and cash equivalents | 48,876,000 | 4,168,000 | -30,983,000 | 4,793,000 | 33,118,000 | 1,236,000 | 7,642,000 | -33,540,000 | 1,100,000 | 18,054,000 | 9,000 | -41,842,000 | -16,364,000 | 29,066,000 | 14,770,000 | 26,352,000 | 9,977,000 | ||||
share-based and deferred compensation | |||||||||||||||||||||
unrealized (appreciation) depreciation on investments | 371,000 | ||||||||||||||||||||
loss on equity method investment | 9,000 | 57,000 | 70,000 | 65,000 | 92,000 | 150,000 | 4,000 | 224,000 | 167,000 | 202,000 | 137,000 | ||||||||||
loss on disposal of property and equipment due to restructuring | |||||||||||||||||||||
investment management fees receivable | |||||||||||||||||||||
fund administration and distribution fees receivable | |||||||||||||||||||||
other receivables | |||||||||||||||||||||
deferred compensation plan liability | |||||||||||||||||||||
purchases of deferred compensation plan investments | |||||||||||||||||||||
sales of deferred compensation plan investments | |||||||||||||||||||||
purchases of proprietary funds | |||||||||||||||||||||
sales of proprietary funds | |||||||||||||||||||||
acquisition of business, net of cash acquired | |||||||||||||||||||||
repayment and repurchases of long-term senior debt | |||||||||||||||||||||
deferred financing costs and derivative and accretion expense | 1,125,000 | 1,171,000 | 775,000 | 811,000 | 861,000 | 983,000 | 1,057,000 | 1,105,000 | 1,132,000 | 1,174,000 | 623,000 | 593,000 | 605,000 | 624,000 | 651,000 | 995,000 | |||||
purchase of equity method investment | 0 | -1,500,000 | |||||||||||||||||||
acquisition of business and assets, net of cash acquired | -553,000 | -327,000 | |||||||||||||||||||
repayments of long-term senior debt | |||||||||||||||||||||
unrealized appreciation on investments | 477,000 | ||||||||||||||||||||
gain on equity method investment | |||||||||||||||||||||
(purchase) sale of equity method investment | -23,000 | ||||||||||||||||||||
repayment of promissory note | 0 | 0 | 0 | -96,000 | -144,000 | -144,000 | |||||||||||||||
cost of asset acquisition | -379,000 | -177,000 | -30,000 | ||||||||||||||||||
issuance of class a common stock | |||||||||||||||||||||
issuance of class b common stock from exercise of stock options | 1,892,000 | 1,553,000 | 790,000 | 1,505,000 | 1,428,000 | 1,000 | 1,693,000 | 1,961,000 | 735,000 | 221,000 | |||||||||||
repayments and repurchases of long-term senior debt | -35,000,000 | ||||||||||||||||||||
receipt of consideration for acquisition | 0 | 649,000 | |||||||||||||||||||
issuance of class a common stock, net of underwriter discount | 53,000 | 44,000 | 42,000 | 35,000 | 32,000 | 26,000 | 18,000 | 15,000 | 16,000 | 13,000 | 0 | 0 | 0 | 156,549,000 | |||||||
loss on other receivable | 689,000 | 195,000 | |||||||||||||||||||
accounts payable | |||||||||||||||||||||
accrued expenses | |||||||||||||||||||||
payment of class a common stock deferred offering costs | 0 | 2,000 | |||||||||||||||||||
payment of equity awards modified to liabilities | |||||||||||||||||||||
net gain on equity method investment | |||||||||||||||||||||
purchases of trading securities | -1,611,000 | -1,024,000 | -2,617,000 | -1,988,000 | -1,552,000 | -1,521,000 | -1,533,000 | ||||||||||||||
sales of trading securities | 1,289,000 | 899,000 | 1,091,000 | 907,000 | 865,000 | 570,000 | |||||||||||||||
purchases of available-for-sale securities | -1,000 | -78,000 | 0 | ||||||||||||||||||
sales of available-for-sale securities | 0 | 0 | |||||||||||||||||||
acquisition of business | 0 | ||||||||||||||||||||
receipt (payment) of consideration for acquisition | |||||||||||||||||||||
amortization of deferred financing fees and accretion expense | |||||||||||||||||||||
net (gain) loss on equity method investment | 0 | ||||||||||||||||||||
disposal of property and equipment due to restructuring | |||||||||||||||||||||
proceeds from sales of trading securities | |||||||||||||||||||||
proceeds from sales of available-for-sale securities | |||||||||||||||||||||
proceeds from (investments in) equity method investment | |||||||||||||||||||||
issuance of common stock, net of costs | |||||||||||||||||||||
issuance of class b common stock | 571,000 | 669,000 | 0 | 10,000 | |||||||||||||||||
issuance of class a common stock under 2018 espp | 14,000 | ||||||||||||||||||||
excess tax benefits on share-based compensation | |||||||||||||||||||||
repayment of draw on line of credit | |||||||||||||||||||||
deferred financing costs and accretion expense | |||||||||||||||||||||
equity method investment | -1,000,000 | -1,000,000 | |||||||||||||||||||
sale of equity method investment | |||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of period | |||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period | |||||||||||||||||||||
reconciliation of cash, cash equivalents and restricted cash | |||||||||||||||||||||
cash and cash equivalents | |||||||||||||||||||||
restricted cash | |||||||||||||||||||||
cash, cash equivalents and restricted cash at end of period | |||||||||||||||||||||
supplemental disclosure of non-cash item | |||||||||||||||||||||
class a common stock offering costs reclassed from prepaid expenses and accounts payable and accrued expenses to additional paid in capital | 4,123,000 | ||||||||||||||||||||
net income/ | |||||||||||||||||||||
purchase and sale of options | |||||||||||||||||||||
proceeds from draw on line of credit | |||||||||||||||||||||
supplemental disclosure of non-cash items | |||||||||||||||||||||
promissory note issued for repurchase of common stock and equity awards | |||||||||||||||||||||
class a common stock offering costs reclassed from prepaid expenses to additional paid in capital | 0 | ||||||||||||||||||||
settlement of compensation liability with issuance of restricted share awards | 0 | ||||||||||||||||||||
net cash used by financing activities |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
